Evaluating the safety of Liptruzet (ezetimibe and atorvastatin): what are the potential benefits beyond low-density lipoprotein cholesterol-lowering effect?
about
Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directionsThe Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease.Recurrence and Severe Worsening of Hepatotoxicity After Reintroduction of Atorvastatin in Combination With Ezetimibe.
P2860
Evaluating the safety of Liptruzet (ezetimibe and atorvastatin): what are the potential benefits beyond low-density lipoprotein cholesterol-lowering effect?
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Evaluating the safety of Liptr ...... n cholesterol-lowering effect?
@en
type
label
Evaluating the safety of Liptr ...... n cholesterol-lowering effect?
@en
prefLabel
Evaluating the safety of Liptr ...... n cholesterol-lowering effect?
@en
P2093
P2860
P1476
Evaluating the safety of Liptr ...... n cholesterol-lowering effect?
@en
P2093
Abdallah Tarig Hassan
Mohamed H Ahmed
Nazik Elmalaika Husain
Wadie M Elmadhoun
P2860
P304
P356
10.1517/14740338.2015.1063613
P407
P577
2015-07-02T00:00:00Z